Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Delayed Quote USD

Cullinan Therapeutics, Inc. (CGEM)

Compare
7.49
-0.33
(-4.22%)
At close: April 3 at 4:00:02 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-145,303
-145,303
-134,275
-126,664
-43,433
Investing Cash Flow
-136,314
-136,314
35,806
248,975
-333,775
Financing Cash Flow
266,188
266,188
40,751
-25,933
268,784
End Cash Position
83,005
83,005
98,434
156,152
59,774
Income Tax Paid Supplemental Data
--
--
--
37,801
--
Interest Paid Supplemental Data
--
--
--
32
--
Capital Expenditure
--
--
-208
-1,133
--
Issuance of Capital Stock
262,652
262,652
38,388
--
267,268
Issuance of Debt
--
--
1,825
2,375
--
Repayment of Debt
--
--
--
-2,200
--
Free Cash Flow
-145,303
-145,303
-134,483
-127,797
-43,433
12/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IDYA IDEAYA Biosciences, Inc.
15.57
-4.77%
 
DNTH Dianthus Therapeutics, Inc.
16.97
-4.98%
 
BCAX Bicara Therapeutics Inc.
11.83
-10.78%
 
KYMR Kymera Therapeutics, Inc.
23.69
-10.13%
 
NUVL Nuvalent, Inc.
68.32
-3.04%
 
DSGN Design Therapeutics, Inc.
3.5200
-7.12%
 
PTGX Protagonist Therapeutics, Inc.
46.50
-3.53%
 
ATXS Astria Therapeutics, Inc.
5.15
-6.70%
 
IPSC Century Therapeutics, Inc.
0.4590
-2.28%
 
KYTX Kyverna Therapeutics, Inc.
1.9700
-8.37%